Cargando…

Stereotactic body radiation therapy for centrally-located lung tumors

The application of high-dose irradiation to centrally-located lung tumors is generally considered to be of high risk in causing bronchial injury. The aim of the present retrospective study was to investigate the safety and efficacy of stereotactic body radiation therapy (SBRT) for patients with cent...

Descripción completa

Detalles Bibliográficos
Autores principales:	SHEN, GE, WANG, YING-JIE, SHEN, WEN-JIANG, ZHOU, ZHEN-SHAN, WANG, JUN-LIANG, SHENG, HONG-GUO, DONG, DA-PENG, ZHOU, MING, YANG, GANG, WANG, QIN-WEN, ZENG, YANJUN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961379/ https://www.ncbi.nlm.nih.gov/pubmed/24944711 http://dx.doi.org/10.3892/ol.2014.1815

Ejemplares similares

Outcomes and toxicity of stereotactic body radiation therapy for advanced stage ultra‐central non‐small cell lung cancer
por: Cong, Yang, et al.
Publicado: (2019)

Risk‐adapted stereotactic body radiation therapy for central and ultra‐central early‐stage inoperable non‐small cell lung cancer
por: Meng, Mao‐Bin, et al.
Publicado: (2019)

Clinical outcomes and prognostic factors of stereotactic body radiation therapy for intrahepatic cholangiocarcinoma
por: Shen, Ze-Tian, et al.
Publicado: (2017)

Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery
por: Kim, Mi-Sook, et al.
Publicado: (2015)

Stereotactic body radiotherapy for centrally-located lung tumors with 56 Gy in seven fractions: A retrospective study
por: Aoki, Shuri, et al.
Publicado: (2018)

Effectiveness of Repeated Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma—Consideration of the Locations of Target Lesions
por: Yano, Shigeki, et al.
Publicado: (2023)

Prognosis and Risk Factors of Radiation-Induced Lymphopenia in Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy
por: Zhao, Qianqian, et al.
Publicado: (2020)

Case report: Stereotactic body radiation therapy with 12 Gy for silencing refractory ventricular tachycardia
por: Huang, Shan-Hui, et al.
Publicado: (2022)

Neoadjuvant Programmed Cell Death Protein 1 Blockade Combined With Stereotactic Body Radiation Therapy for Stage III(N2) Non-Small Cell Lung Cancer: A Case Series
por: Wang, Zhen, et al.
Publicado: (2022)

Stereotactic body radiation therapy for metastatic lung metastases
por: Kimura, Tomoki, et al.
Publicado: (2022)

Analysis of the efficacy, safety and survival factors of stereotactic body radiation therapy in patients with recurrence of pancreatic cancer
por: Li, Jing, et al.
Publicado: (2020)

A treatment-planning comparison of three beam arrangement strategies for stereotactic body radiation therapy for centrally located lung tumors using volumetric-modulated arc therapy
por: Ishii, Kentaro, et al.
Publicado: (2016)

Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm
por: Su, Ting-Shi, et al.
Publicado: (2016)

Lung stereotactic body radiation therapy: personalized PTV margins according to tumor location and number of four-dimensional CT scans
por: Trémolières, Pierre, et al.
Publicado: (2022)

Magnetic Resonance-Guided Stereotactic Body Radiation Therapy/Hypofractionated Radiation therapy for Metastatic and Primary Central and Ultracentral Lung Lesions
por: Sandoval, Maria L., et al.
Publicado: (2023)

Quality assurance of four-dimensional computed tomography in a multicentre trial of stereotactic body radiotherapy of centrally located lung tumours
por: Lambrecht, Marie, et al.
Publicado: (2018)

An optimal dose‐fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early‐stage non‐small lung cancer
por: Zarębska, Izabela, et al.
Publicado: (2023)

Early efficacy of stereotactic body radiation therapy combined with adoptive immunotherapy for advanced malignancies
por: WANG, YI-SHAN, et al.
Publicado: (2013)

Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy Cost-Effectiveness Results
por: Bijlani, Akash, et al.
Publicado: (2013)

Frameless stereotactic body radiation therapy for multiple lung metastases
por: Li, Qilin, et al.
Publicado: (2014)

Correction to: Stereotactic body radiation therapy for metastatic lung metastases
por: Kimura, Tomoki, et al.
Publicado: (2022)

Conformal Radiation Therapy or Stereotactic Body Radiation Therapy: Institutional Experience in the Management of Colorectal Liver Metastases by Radiation Therapy
por: He, Zemin, et al.
Publicado: (2018)

Clinical Outcomes and Prognostic Factors of Salvage Stereotactic Body Radiotherapy for Post-Surgical Thoracic Oligo-Recurrence/Metastasis of Non-Small-Cell Lung Cancer
por: Li, Wen-Cai, et al.
Publicado: (2021)

Stereotactic body radiation therapy for metastatic non-small cell lung cancer: a versatile treatment, repurposed
por: Shen, James L., et al.
Publicado: (2022)

Impact of tumor size and location on lung dose difference between stereotactic body radiation therapy techniques for non‐small cell lung cancer
por: Jang, Seong Soon, et al.
Publicado: (2021)

Dose calculation differences between Monte Carlo and pencil beam depend on the tumor locations and volumes for lung stereotactic body radiation therapy
por: Zhuang, Tingliang, et al.
Publicado: (2013)

Stereotactic Body Radiation Therapy for Spinal Malignancies
por: Osborn, Virginia W., et al.
Publicado: (2018)

Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry
por: Davis, Joanne N., et al.
Publicado: (2015)

Development and clinical validation of a robust knowledge‐based planning model for stereotactic body radiotherapy treatment of centrally located lung tumors
por: Visak, Justin, et al.
Publicado: (2020)

Stereotactic body radiation therapy for post-pulmonary lobectomy isolated lung metastasis of thoracic tumor: survival and side effects
por: Xiong, Weijie, et al.
Publicado: (2014)

Radiation-Induced Dyspnea in Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy
por: Cella, Laura, et al.
Publicado: (2021)

Wedge Resection vs. Stereotactic Body Radiation Therapy for Clinical Stage I Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Peng, Lei, et al.
Publicado: (2022)

Stereotactic body radiation therapy using the CyberKnife(®) system for patients with liver metastases
por: Yuan, Zhi-Yong, et al.
Publicado: (2014)

First Asian population study of stereotactic body radiation therapy for ventricular arrhythmias
por: Ho, Li-Ting, et al.
Publicado: (2021)

Repeated CyberKnife stereotactic body radiation therapy in hepatocellular carcinoma
por: Sun, Jing, et al.
Publicado: (2020)

Prognostic role of stereotactic body radiation therapy for elderly patients with advanced and medically inoperable pancreatic cancer
por: Zhu, Xiaofei, et al.
Publicado: (2017)

Delayed esophageal perforation from stereotactic body radiation therapy for locally recurrent central nonsmall cell lung cancer
por: Sainathan, Sandeep, et al.
Publicado: (2014)

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
por: Kunos, Charles A., et al.
Publicado: (2015)

Safety of Stereotactic Body Radiation Therapy for Seven Ipsilateral Lung Lesions
por: Bernard, Mark E, et al.
Publicado: (2020)

Surface guided frameless positioning for lung stereotactic body radiation therapy
por: Sarudis, Sebastian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0fq9lqekr89ih39s7icsqs2cvk